New synthetic approaches, such as combinatorial chemistry, provide a rich source of potential drug candidates. At the same time, the human genome initiative and other large-scale sequencing projects provide a large number of novel drug targets. However, the functional analysis of thousands of new genes remains a major challenge for the future. A systematic strategy for genome-wide functional analysis of genes could employ the fact that at least some modules in multi-domain proteins are encoded in individual exons. Exon amplification provides information about coding regions of most genes that is independent of their transcriptional status; exon amplification from entire mammalian genomes has been demonstrated. Here, we describe the development of an exon-trap system, λGEE (for genomic exon expression), that couples exon amplification with the expression of exon-encoded peptides.
A schematic diagram of the λGEE phage vectors accommodating all three possible intron phases is shown in Figure 1 . Chimaeric transcripts containing insert-derived exon sequences are translated into fusion proteins consisting of a leader peptide and a stretch of six histidine residues followed by the exon-encoded peptide. The hydrophobic leader peptide was incorporated into the fusion protein to allow its secretion into the medium, whereas the His-tag facilitates its affinity purification (1) . To demonstrate this system, a genomic fragment (2) spanning the exon encoding the E47 bHLH domain of the human E2A gene (3) was cloned into λGEE-1, -2 and -3. Western blot analysis using a monoclonal antibody specific for the human E47 protein revealed the presence of an immunoreactive peptide of ∼14 kDa only in the supernatant of cells transfected with a plasmid derived from λGEE-2, the construct providing the correct phase after the splicing process (Fig. 2) . In electrophoretic mobility shift assays, complexes between the secreted peptide and an oligonucleotide containing a specific DNA-binding site for the E47 bHLH domain (4) are readily detected indicating that the secreted peptide is biologically active. Using a bacterially expressed human E47 protein (Santa Cruz) as a standard, the E47 fusion protein is produced at a rate of ∼1 ng (or 0.1 pmol)/10 6 cells/h.
Because of their large insert capacity and high cloning efficiency, λGEE vectors can be used to construct complete highly redundant genomic libraries from mammalian genomes with a reasonable number of recombinants (∼10 6 ) as previously shown for the λGET vector (5). However, with the λGEE system, the parallel preparation , which itself is a derivative of pL53In (7) . λGEE was constructed by replacing a 420 bp HindIII-XmnI fragment encompassing the first exon and ∼20 bp of the first intron in λGET with a 145 bp fragment assembled from overlapping synthetic oligonucleotides. Inserts of up to 19 kb can be inserted into either the XhoI (X) or BamHI (B) cloning sites to replace the λGEE stuffer fragment. The reporter plasmid is flanked by loxP sites situated in tandem orientation adjacent to the phage arms. Transduction into a cre-recombinase expressing bacterial strain effects the conversion of phage to a multi-copy plasmid, whose structure is shown in the lower panel. The HindIII (H)-XmnI (Xm) sites of the λGET vector are indicated. (B) Sequence of the first exon in λGEE vectors. The nucleotide sequence of the HindIII-XmnI fragment is shown and the conceptual translation given in single-letter code. The first exon of λGEE vectors encodes a 19 amino acid leader peptide from an immunoglobulin heavy chain variable region gene (17) (cleavage site is indicated by an arrow), a stretch of six histidine residues and a glycine/serine-rich linker peptide preceding the splice site. The intron occurs in different phases in the three λGEE versions. In λGEE1, it occurs in phase 0, that is after the last base of the codon; in λGEE2, the intron lies after the second base (phase 2), whereas in λGEE3, it occurs before the second base (phase 1) within the codon. This arrangement ensures that for any cloned exon, one of the vectors will preserve the correct reading frame.
of three libraries is required, one for each λGEE version, to accommodate the three possible phases of introns. Such libraries could then be screened with probes specific for individual genes or *To whom correspondence should be addressed. Tel: +49 6221 42 3350; Fax: +49 6221 42 3352; Email: t.boehm@dkfz-heidelberg.de A genomic fragment encompassing the E47 bHLH exon of the human E2A gene (2,3) was cloned in correct orientation into the three GEE vectors, and the plasmids transfected into COS7 cells (5) . Twenty-four hours after transfection, the complete medium was removed, the cells washed once with PBS and supplied with serum-free synthetic medium (AIM V-research grade, Gibco BRL) for 24-48 h. The result of a Western blot analysis with a monoclonal anti-human-E47 antibody is shown in the upper panel, part of a Coomassiestained gel with proteins from the culture supernatant is shown in the bottom panel. Proteins were separated by denaturing SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes (Hybond C, Amersham). Membranes were incubated with mouse anti-human E47 antibody (clone G127-32.1, Pharmingen) at 1 µg/ml, followed by goat anti-mouse-IgGFc -alkaline phosphatase-coupled antibody (Jackson) used at 1:20 000 dilution. Immune complex formation was detected using a chemiluminescent detection system (Tropix Western-Light Plus) and autoradiography. Note that a correct E47 peptide is only made in cells transfected with the GEE vector providing a phase 2 intron, as expected from the sequence of the E47 exon (2, 3) shown in (A). (C) Electrophoretic mobility shift assays (18) with secreted peptides in the presence of 50 mM imidazole. An E-box containing radio-labeled oligonucleotide was used. Culture medium from COS7 cells transfected with GEE1-E47, GEE2-E47 or GEE3-E47 recombinants (equivalent of 100 µl of original culture medium per lane) were used after purification using Ni-chelate agarose (Qiagen) affinity chromatography: ∼15 µl packed beads were equilibrated in PBS, 1% Tween 20, 10 mM 2-mercaptoethanol, finally resuspended with 1 ml of culture supernatant, and incubated for 1 h at 4_C with constant agitation. The supernatant was removed and beads washed three times in 30 bed vol of PBS, 1% Tween 20, 10 mM 2-mercaptoethanol. The bound material was finally eluted in PBS containing 500 mM imidazole. A bacterially expressed, slightly smaller version of the E47-bHLH protein was used as a positive control (+; complex A). Note that specific protein-DNA complexes (complex B) are only seen with the GEE2-E47 recombinant, consistent with the results shown in (A).
gene families, and subsequently subjected to exon expression. The large insert capacity of λGEE is an advantage in cases where a functional protein domain is encoded by more than one exon, as the cloning of large genomic fragments increases the chance of co-representation of such exons in a single recombinant. Indeed, previous experience indicates that co-splicing of multiple exons located in cloned insert fragments regularly occurs (6) . There are several features of the present system that distinguish it from cDNA expression systems. Exon trapping/expression is independent of the source of mRNA and begins with an equalized source of starting material, i.e. genomic DNA. While the efficiency with which individual exons are trapped from genomic DNA may vary (5-10), previous results have indicated that this variation is orders of magnitude smaller than that observed in mRNA populations (6) . Peptides that are expressed with the λGEE system reflect exon boundaries, whereas the ends of cDNAs are essentially randomly distributed across the length of the mRNA molecules. In many cases, peptides encoded by single or co-spliced exons will contain functional units (11) (12) (13) , as exemplified here by the E47 DNAbinding domain. However, even when an entire functional domain is not formed, it might exert a biologically relevant effect, for instance by antagonizing biologically important protein interactions. While the analysis of individual λGEE clones is fairly straightforward, it may be difficult to predict the optimal pool size of λGEE recombinants representing large regions of the genome. Our previous experience (6), however, suggests that the splicing process itself will not be the limiting factor; rather, it appears more likely that the translation efficiency of chimaeric mRNAs and the stability of synthesized peptides will ultimately determine the outcome of screening programs.
Nevertheless, compared with the vast size of the molecular repertoire in synthetic libraries (14) (15) (16) , the repertoire of protein domains encoded in ∼500 000 trappable exons of a mammalian genome (6) is finite and small. Our results with the λGEE system therefore suggest a novel strategy to explore the structure-function relationship of evolutionarily selected coding information embedded in metazoan genomes especially in cases where the coding capacity is not well known.
